CommercialCoverageMedium impact
08.02.42, Penpulimab-kcqx
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Dec 29, 2025
We identified it
Jun 19, 2026
Summary
A new pharmacy policy for Penpulimab-kcqx (likely a cancer immunotherapy drug) has been created for commercial insurance plans. This policy will establish coverage criteria, prior authorization requirements, or billing guidelines for this medication starting December 29, 2025.
Action Required
Before December 29, 2025: Review the complete policy document at the provided URL to understand specific coverage criteria, prior authorization requirements, and billing procedures for Penpulimab-kcqx. Update pharmacy benefit management protocols and inform providers who prescribe oncology medications about any new requirements.